|
시장보고서
상품코드
2055285
안과용 의약품 시장 : 적응증별, 유형별, 제형별, 유통 채널별, 치료 분류별, 지역별Ophthalmic Drugs Market, By Indication, By Type, By Dosage Form, By Distribution Channel, By Therapeutic Class, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
안과용 의약품 시장은 2026년 569억 2,000만 달러로 추정되고, 2033년에 846억 9,000만 달러에 이를 전망입니다. 또한, 2026-2033년 CAGR 5.8%를 기록할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 569억 2,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 5.80% | 2033년 시장 규모 예측 : | 846억 9,000만 달러 |
안과는 눈의 건강에 중점을 둔 의료 분야입니다. 여기에는 해부학, 생리학, 그리고 눈에 영향을 미칠 수 있는 질환이 포함됩니다. 한편, 안과용 의약품은 백내장, 녹내장, 감염증, 알레르기, 염증, 망막 질환(습성 노인성 황반변성, 건성 노인성 황반변성, 당뇨성 망막병증, 기타), 기타 안과 질환 등 눈과 관련된 다양한 질환의 치료에 사용됩니다.
시장 역학
안과 질환 유병률의 상승, 고령 인구 증가, 안전하고 효과적인 안과용 의약품에 대한 수요 증가, 안과용 의약품 개발에 대한 관심 고조, 연구 개발 확대는 예측 기간 동안 전 세계 안과용 의약품 시장의 성장을 견인할 것으로 예상되는 주요 요인입니다.
예를 들어, 2022년 4월, 샌드사는 고안압증 환자의 안압을 낮추기 위한 복합 제네릭 안약인 ‘브리모니딘 타르트레이트/티모롤 말레이트 안약 0.2%/0.5%’(애비사의 'COMBIGAN'에 상응하는 AB 동등성 제네릭)의 미국 내 출시를 발표했습니다. 또한, 2022년 3월에는 Thea Pharma가 Akorn Operating Company LLC로부터 7개의 안과 브랜드 제품을 인수함으로써, 미국 안과 전문의들의 요구를 충족시키기 위해 개발된 제품의 주요 공급업체로서의 입지를 공고히 했습니다.
본 조사의 주요 특징
- 본 조사는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 안과용 의약품 시장의 주요 기업 프로파일을 작성하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 세계 안과용 의약품 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 안과용 의약품 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 안과용 의약품 시장 : 적응증별, 2021-2033년
제5장 세계의 안과용 의약품 시장 : 유형별, 2021-2033년
제6장 세계의 안과용 의약품 시장 : 제형별, 2021-2033년
제7장 세계의 안과용 의약품 시장 : 유통 채널별, 2021-2033년
제8장 세계의 안과용 의약품 시장 : 치료 분류별, 2021-2033년
제9장 세계의 안과용 의약품 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
LSH 26.06.23Ophthalmic Drugs Market is estimated to be valued at USD 56.92 Bn in 2026 and is expected to reach USD 84.69 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 56.92 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 84.69 Bn |
Ophthalmology is a specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology, and diseases that may affect the eye. Whereas, ophthalmic drugs are used to treat various disorders associated with the eyes, such as cataracts, glaucoma, infection, allergy, and inflammation, retinal disorders (such as wet age-related macular degeneration, dry age-related macular degeneration, diabetic retinopathy, and others), and other ophthalmic disorders.
Market Dynamics
Rise in prevalence of ophthalmic disorders, growing geriatric population, rise in demand for safe and effective ophthalmic drugs, rise in focus on the development of ophthalmic drugs, and increase in research and development are major factors expected to propel growth of the global ophthalmic drugs market during the forecast period.
For instance, in April 2022, Sandoz announced the US launch of its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, AB-rated generic equivalent to AbbVie's COMBIGAN, to lower eye pressure in patients with ocular hypertension. Moreover, in March 2022, Thea Pharma acquired seven branded ophthalmic products from Akorn Operating Company LLC to strengthen its position as a significant provider of products developed to satisfy the demands of eye care specialists across the United States.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global ophthalmic drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbvie Inc. (Allergan Plc), Alcon, Inc., Novartis AG, Pfizer Inc., Bausch & Lomb Incorporated, F. Hoffmann-LA Roche Ltd. (Genentech, Inc.), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global ophthalmic drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ophthalmic drugs market.
Market Segmentation
- Global Ophthalmic Drugs Market, By Indication (Revenue, USD Bn, 2021 - 2033)
- Dry Eye
- Glaucoma
- Infection/Inflammation/Allergy
- Retinal Disorder
- Wet Age-related Macular Degeneration
- Dry Age-related Macular Degeneration
- Diabetic Retinopathy
- Others
- Others
- Global Ophthalmic Drugs Market, By Type (Revenue, USD Bn, 2021 - 2033)
- Prescription Drugs
- Over-the-counter Drugs
- Global Ophthalmic Drugs Market, By Dosage Form (Revenue, USD Bn, 2021 - 2033)
- Liquid Ophthalmic Drug Forms
- Solid Ophthalmic Drug Forms
- Semisolid Ophthalmic Drug Forms
- Multicompartment Drug Delivery Systems
- Other Ophthalmic Drug Forms
- Global Ophthalmic Drugs Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- Others
- Global Ophthalmic Drugs Market, By Therapeutic Class (Revenue, USD Bn, 2021 - 2033)
- Anti-glaucoma
- Anti-infection
- Anti-inflammation
- Anti-allergy
- Others
- Global Ophthalmic Drugs Market, By Geography (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Global Ophthalmic Drugs Market: Key Companies Insights
- Abbvie Inc. (Allergan Plc)
- Alcon, Inc.
- Novartis AG
- Pfizer Inc.
- Bausch & Lomb Incorporated
- Hoffmann-LA Roche Ltd. (Genentech, Inc.)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Indication
- Market Snapshot, By Type
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Therapeutic Class
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of ophthalmic disorders
- Risks associated with ophthalmic drugs
- High demand for safe/effective ophthalmic drugs
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Ophthalmic Drugs Market, By Indication, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Dry Eye
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Infection/Inflammation/Allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Retinal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Wet Age-related Macular Degeneration
- Dry Age-related Macular Degeneration
- Diabetic Retinopathy
- Others
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
5. Global Ophthalmic Drugs Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Over-the-counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
6. Global Ophthalmic Drugs Market, By Dosage Form, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Liquid Ophthalmic Drug Forms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Solid Ophthalmic Drug Forms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Semisolid Ophthalmic Drug Forms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Multicompartment Drug Delivery Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Other Ophthalmic Drug Forms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
7. Global Ophthalmic Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Drug Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
8. Global Ophthalmic Drugs Market, By Therapeutic Class, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Anti-glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Anti-infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Anti-inflammation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Anti-allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
9. Global Ophthalmic Drugs Market, By Geography, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)
10. Competitive Landscape
- Abbvie Inc. (Allergan Plc)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alcon, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bausch & Lomb Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-LA Roche Ltd. (Genentech, Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
